275 related articles for article (PubMed ID: 19996179)
1. Human Langerhans cells induce distinct IL-22-producing CD4+ T cells lacking IL-17 production.
Fujita H; Nograles KE; Kikuchi T; Gonzalez J; Carucci JA; Krueger JG
Proc Natl Acad Sci U S A; 2009 Dec; 106(51):21795-800. PubMed ID: 19996179
[TBL] [Abstract][Full Text] [Related]
2. Differential capacity of human skin dendritic cells to polarize CD4+ T cells into IL-17, IL-21 and IL-22 producing cells.
Penel-Sotirakis K; Simonazzi E; Péguet-Navarro J; Rozières A
PLoS One; 2012; 7(11):e45680. PubMed ID: 23226194
[TBL] [Abstract][Full Text] [Related]
3. Psoriasis is characterized by accumulation of immunostimulatory and Th1/Th17 cell-polarizing myeloid dendritic cells.
Zaba LC; Fuentes-Duculan J; Eungdamrong NJ; Abello MV; Novitskaya I; Pierson KC; Gonzalez J; Krueger JG; Lowes MA
J Invest Dermatol; 2009 Jan; 129(1):79-88. PubMed ID: 18633443
[TBL] [Abstract][Full Text] [Related]
4. Thymic stromal lymphopoietin converts human epidermal Langerhans cells into antigen-presenting cells that induce proallergic T cells.
Ebner S; Nguyen VA; Forstner M; Wang YH; Wolfram D; Liu YJ; Romani N
J Allergy Clin Immunol; 2007 Apr; 119(4):982-90. PubMed ID: 17320941
[TBL] [Abstract][Full Text] [Related]
5. Langerhans cells from human cutaneous squamous cell carcinoma induce strong type 1 immunity.
Fujita H; Suárez-Fariñas M; Mitsui H; Gonzalez J; Bluth MJ; Zhang S; Felsen D; Krueger JG; Carucci JA
J Invest Dermatol; 2012 Jun; 132(6):1645-55. PubMed ID: 22402444
[TBL] [Abstract][Full Text] [Related]
6. Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells.
Klechevsky E; Morita R; Liu M; Cao Y; Coquery S; Thompson-Snipes L; Briere F; Chaussabel D; Zurawski G; Palucka AK; Reiter Y; Banchereau J; Ueno H
Immunity; 2008 Sep; 29(3):497-510. PubMed ID: 18789730
[TBL] [Abstract][Full Text] [Related]
7. The differential production of cytokines by human Langerhans cells and dermal CD14(+) DCs controls CTL priming.
Banchereau J; Thompson-Snipes L; Zurawski S; Blanck JP; Cao Y; Clayton S; Gorvel JP; Zurawski G; Klechevsky E
Blood; 2012 Jun; 119(24):5742-9. PubMed ID: 22535664
[TBL] [Abstract][Full Text] [Related]
8. IL-23 from Langerhans cells is required for the development of imiquimod-induced psoriasis-like dermatitis by induction of IL-17A-producing γδ T cells.
Yoshiki R; Kabashima K; Honda T; Nakamizo S; Sawada Y; Sugita K; Yoshioka H; Ohmori S; Malissen B; Tokura Y; Nakamura M
J Invest Dermatol; 2014 Jul; 134(7):1912-1921. PubMed ID: 24569709
[TBL] [Abstract][Full Text] [Related]
9. Human epidermal Langerhans cells differ from monocyte-derived Langerhans cells in CD80 expression and in secretion of IL-12 after CD40 cross-linking.
Peiser M; Wanner R; Kolde G
J Leukoc Biol; 2004 Sep; 76(3):616-22. PubMed ID: 15178702
[TBL] [Abstract][Full Text] [Related]
10. TLR-stimulated CD34 stem cell-derived human skin-like and monocyte-derived dendritic cells fail to induce Th17 polarization of naive T cells but do stimulate Th1 and Th17 memory responses.
Duraisingham SS; Hornig J; Gotch F; Patterson S
J Immunol; 2009 Aug; 183(4):2242-51. PubMed ID: 19625644
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of Langerhans Cells from Monocytes and Their Specific Function in Inducing IL-22-Specific Th Cells.
Otsuka Y; Watanabe E; Shinya E; Okura S; Saeki H; Geijtenbeek TBH; Takahashi H
J Immunol; 2018 Nov; 201(10):3006-3016. PubMed ID: 30322965
[TBL] [Abstract][Full Text] [Related]
12. Dynamic Changes in Resident and Infiltrating Epidermal Dendritic Cells in Active and Resolved Psoriasis.
Martini E; Wikén M; Cheuk S; Gallais Sérézal I; Baharom F; Ståhle M; Smed-Sörensen A; Eidsmo L
J Invest Dermatol; 2017 Apr; 137(4):865-873. PubMed ID: 28011143
[TBL] [Abstract][Full Text] [Related]
13. FcepsilonRI engagement of Langerhans cell-like dendritic cells and inflammatory dendritic epidermal cell-like dendritic cells induces chemotactic signals and different T-cell phenotypes in vitro.
Novak N; Valenta R; Bohle B; Laffer S; Haberstok J; Kraft S; Bieber T
J Allergy Clin Immunol; 2004 May; 113(5):949-57. PubMed ID: 15131579
[TBL] [Abstract][Full Text] [Related]
14. Psoriasis and other Th17-mediated skin diseases.
Tokura Y; Mori T; Hino R
J UOEH; 2010 Dec; 32(4):317-28. PubMed ID: 21226422
[TBL] [Abstract][Full Text] [Related]
15. TIM-4 is differentially expressed in the distinct subsets of dendritic cells in skin and skin-draining lymph nodes and controls skin Langerhans cell homeostasis.
Zhang X; Liu Q; Wang J; Li G; Weiland M; Yu FS; Mi QS; Gu J; Zhou L
Oncotarget; 2016 Jun; 7(25):37498-37512. PubMed ID: 27224924
[TBL] [Abstract][Full Text] [Related]
16. IL-21 promotes skin recruitment of CD4(+) cells and drives IFN-γ-dependent epidermal hyperplasia.
Sarra M; Caruso R; Cupi ML; Monteleone I; Stolfi C; Campione E; Diluvio L; Mazzotta A; Botti E; Chimenti S; Costanzo A; MacDonald TT; Pallone F; Monteleone G
J Immunol; 2011 May; 186(9):5435-42. PubMed ID: 21441456
[TBL] [Abstract][Full Text] [Related]
17. Langerhans cells prime IL-17-producing T cells and dampen genital cytotoxic responses following mucosal immunization.
Hervouet C; Luci C; Rol N; Rousseau D; Kissenpfennig A; Malissen B; Czerkinsky C; Anjuère F
J Immunol; 2010 May; 184(9):4842-51. PubMed ID: 20351191
[TBL] [Abstract][Full Text] [Related]
18. Epidermal and dermal dendritic cells display differential activation and migratory behavior while sharing the ability to stimulate CD4+ T cell proliferation in vivo.
Shklovskaya E; Roediger B; Fazekas de St Groth B
J Immunol; 2008 Jul; 181(1):418-30. PubMed ID: 18566408
[TBL] [Abstract][Full Text] [Related]
19. Differential capability of human cutaneous dendritic cell subsets to initiate Th17 responses.
Mathers AR; Janelsins BM; Rubin JP; Tkacheva OA; Shufesky WJ; Watkins SC; Morelli AE; Larregina AT
J Immunol; 2009 Jan; 182(2):921-33. PubMed ID: 19124735
[TBL] [Abstract][Full Text] [Related]
20. Human langerhans cells are more efficient than CD14(-)CD1c(+) dermal dendritic cells at priming naive CD4(+) T cells.
Furio L; Briotet I; Journeaux A; Billard H; Péguet-Navarro J
J Invest Dermatol; 2010 May; 130(5):1345-54. PubMed ID: 20107482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
